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Abstract: Medication prescribed but not consumed represents a huge loss in drug and 
prescribing costs and an enormous waste of expensive medical time. In this article we discuss 
what is known about compliance and adherence, explore the concept of concordance and 
demonstrate its fundamental difference from both. Not all patients are ready or suitable for 
shared decision making in management of their condition, some still preferring a doctor-led 
decision but an increasing number want a partnership approach. By opening up and rebalanc-
ing the discussion about medication, we can expect a consultation which is more satisfying for 
both parties and ﬂ  owing from this, more effective, focused prescribing of medication which is 
more likely to be adhered to by the patient. We examine the extent to which doctor and patient 
behaviors are currently compatible with this change of concept and practice, look at available 
consultation models which might be useful to the reﬂ  ective practitioner and consider what 
actions on the part of the doctor and the healthcare system could promote medicine prescription 
and utilization in line with this new approach based on partnership.
Keywords: concordance, patient participation, decision making, adherence, physician-patient 
relations, communication
Background
In the United Kingdom, it is estimated that about £100M each year, enough to build 
a sizeable hospital, is wasted on medication dispensed but returned to pharma-
cies (National Audit Office 2007). This is probably just the tip of the iceberg of 
medicines not consumed by the patients for whom they were prescribed (Metcalfe 
2005). Extensive reviews of the literature reveal that in developed countries 
adherence to therapies averages 50% (World Health Organisation 2003; Carter 
et al 2005). Approximately half of this non-adherence is intentional, an active 
“resistance” (Pound et al 2005) whilst the remainder occurs because patients are 
either unaware that they are not taking medication as prescribed or the regime is 
just too complex (Ley 1997). The consequences are waste, morbidity and hospital 
admissions (WHO 2003).
The Evidence Based Clinical Outcomes movement now has a large data-
base of information on effectiveness of therapies but even when good evidence 
is available, translation from theory to practice can be difficult and there are 
few rigorous trials of well-specified interventions to inform practice (Griffin 
et al 2004). Clinical experience needs to be supplemented by outcomes research 
(Tannenbaum 1993) but efficacy in practice is less dependent on improvements 
in specific medical treatments than on adherence which is affected by patient, 
practitioner and healthcare system factors (Haynes, Devereaux et al 2002; Haynes, 
McDonald et al 2002). Hence it is suggested that a model for clinical decision 
making should use evidence but acknowledge the importance of patient factors 
and clinical expertise (Haynes 2004).Therapeutics and Clinical Risk Management 2007:3(6) 1048
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Patient involvement in decision making is a speciﬁ  c 
example of an attitudinal shift in society towards greater 
individual autonomy and choice (Department of Health 2001, 
2002; Wanless 2002). With a shift of burden from acute to 
chronic disease in the population, the active and informed 
involvement of patients to prevent or manage their illnesses is 
desirable. Powerful, complex and intrusive therapies demand 
greater understanding and active participation by the patient 
in decisions about therapy in order to promote greater efﬁ  cacy 
and patient safety (Donaldson 2003; WHO 2003; National 
Patient Safety Agency 2006). When appropriately provided 
with evidence, patients usually make rational choices that 
are often more conservative and involve less risk than their 
doctors would choose (O’Connor et al 1999).
In this article we discuss what is known about compli-
ance and adherence, explore the concept of concordance and 
demonstrate its fundamental difference from both compliance 
and adherence. We consider whether the behaviors of pro-
vider and patient are currently compatible with this change of 
concept and consider what actions on the part of individual 
practitioners and the healthcare systems in which they work 
could help to optimize medicine taking.
Compliance and adherence: 
Deﬁ  nitions and literature review
Compliance is deﬁ  ned as: “the extent to which the patient 
follows the health professionals’ advice and takes the treat-
ment”. This view of a rather passive, obedient patient, whilst 
perhaps an approach expected and preferred by some patients 
is increasingly an obsolete model of care. Its practitioners 
have rarely recognized its inefﬁ  ciency, though this is well 
recorded in even quite old literature (Ley 1982). Patients may 
be deferential in the presence of doctors whilst holding many 
reservations, which they fail to voice (Tuckett 1985). They 
actively make decisions not to take prescribed medication 
and fail to conﬁ  de in their doctors (Stimson 1974; Benson 
and Britten 2002; Pound et al 2005). They also use other self 
administered or complementary therapies which they do not 
declare (Elwyn 2003).
Whilst the term compliance remains in the literature it has 
been superseded more recently by the term adherence. Patient 
adherence is deﬁ  ned as: “… the extent to which a person’s 
behavior – taking medication, following a diet, and/or execut-
ing lifestyle changes, corresponds with agreed recommenda-
tions from a health-care provider” (WHO 2003).
Detailed reviews reveal the complexity of adherence; 
the result of an interplay of a range of factors including 
patient views and attributes, illness characteristics, social 
contexts, access and service issues (Haynes et al 1996; 
Haynes, Devereaux et al 2002; WHO 2003; Cox et al 2004). 
A recent meta-analysis by Simpson et al (2006) showed 
that good adherence was associated with reduced mortality, 
though the reasons may not be as simple as at ﬁ  rst appears 
since a similar beneﬁ  t was also seen for adherence to pla-
cebo. It may be that good adherence behavior is a marker 
for overall healthy behavior but adherence also has its risks 
for good adherers experienced some increase in mortality 
from unwanted drug effects. This supports the point made 
by Pound et al (2006) who suggest the predominant need to 
make medicines themselves safer.
Failure to adhere is, not surprisingly, a particular prob-
lem in the management of chronic illness especially when 
patients do not feel ill (Carter et al 2005). Asthma, diabetes 
and hypertension treatments seem to incur especially high 
levels of non-adherence and it is common for patients to 
alter or abandon therapy without telling their doctor (Sackett 
et al 1978; Ley 1982; WHO 2003).
Patients with depression, anxiety or cognitive impairment, 
the elderly, those on multiple medications and with complex 
regimens, those on preventive medication and with chronic 
illnesses have lower adherence rates (DiMatteo et al 2000; 
Ziegelstein et al 2000; Haynes et al 2000b; Claxton et al 2001; 
Heneghan et al 2006). However, non-adherence still occurs 
in other, more favorable settings and doctors themselves are 
similarly sometimes non-adherent (Ley 1981, 1982).
Evidence that interventions to improve adherence 
are effective is sparse. Cox et al (2004) in their compre-
hensive review suggest that changes to organizational 
practices can be beneficial. For example, increasing the 
frequency of visits to a nurse practitioner for medication 
review enhances attendance and subsequent discussions 
with a doctor. Advertising campaigns aimed at promot-
ing the role of pharmacists have not been shown to 
increase adherence although they do positively influence 
pharmacists’ communication with patients (Airaksinen 
et al 1998). Asking patients to write down questions 
before they see the pharmacist did result in more ques-
tions being asked but did not have any additional impact 
on adherence (Barnett et al 2000).
Extensions in prescribing roles for nurses and supplemen-
tary prescribing by pharmacists mean that optimal medicines 
management is increasingly a team responsibility (Department 
of Health 2002). Unfortunately, Haynes et al (1996, 2002) 
show that even highly developed, complex, labor intensive 
and patient-focused interventions, whilst effective in the 
short term had no effect on adherence over a longer period. Therapeutics and Clinical Risk Management 2007:3(6) 1049
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Use of patient groups to inform and support, expert patient 
programmes, monitoring by administrative staff and improved 
repeat prescribing systems are examples of mechanisms to 
support medicines management and adherence (Bodenheimer 
et al 2002; Donaldson 2003). A “whole systems approach” 
to improving medicines management is intuitively sensible 
and supported by some evidence.
The strongest effects on treatment outcome would seem to 
derive from active involvement of individuals, the promotion 
of self care and social support (Carter et al 2005) and thus, 
whilst recognizing the importance of system factors and the 
clinical team, we concentrate in this review on the interaction 
of the individual patient with the prescribing practitioner and 
the opportunity that this provides to enhance self care and 
active involvement.
Concordance: Redeﬁ  ning the issue
The term “concordance” relates to a process of the 
consultation in which prescribing is based on partnership. 
A subset of shared decision making, the concept was 
introduced by the Medicines Partnership Group established 
in 1996 by the Department of Health in conjunction with 
the Royal Pharmaceutical Society of Great Britain. It is 
defined as: “agreement between the patient and healthcare 
professional, reached after negotiation that respects the 
beliefs and wishes of the patient in determining whether, 
when and how their medicine is taken, and (in which) 
the primacy of the patient’s decision (is recognized)” 
(Marinker et al 1997).
Concordance describes an agreement drawing upon the 
experiences of both provider and patient. Some authors warn 
against the concept being subverted into a subtle form of 
coercion, providing patients with more information but in 
such a way as to indirectly inﬂ  uence outcome (Heath 2003; 
Pollock 2005).The proponents of concordance are, however, 
quite clear about the value of the concept when properly 
applied (RPSGB 1997). There is therefore no such thing as 
patient concordance. The consultation is concordant when 
it involves two-way communication and informed, shared 
decision-making.
The degree to which patients want to be involved in 
decision-making with their practitioner is, in practice, 
variable. In some cases the patient with the aid of the 
practitioner reaches a decision that both parties think 
appropriate. The patient is better informed, more likely 
to be committed to the treatment regime and thus to 
adhere to a decision she has actively made for herself 
(Stewart et al 1999). In practice the patient often asks the 
practitioner’s opinion and defers to that. The challenge 
here is for the professional to delve beneath the surface 
of this deference to ensure that important issues which 
might affect adherence are not being ignored. A third 
possibility is that after considering the options, the 
patient reaches a decision which the practitioner, from 
a biomedical viewpoint, would not recommend. As 
long as the doctor believes the patient has understood 
the issues and there are no ethical concerns, then the 
patient’s decision is supported. At the extreme, the 
doctor may be faced with dissociating him or herself 
from the patient’s decision, though this is in practice 
likely to be a very rare event.
A major advantage to the concordance approach is that the 
doctor will have elicited the patient’s views and the decisions 
will be overt. The patient also knows his or her views are 
respected and any subsequent difﬁ  culties the patient has in 
following the treatment can be discussed. The patient is not, 
subsequently, likely to be in an uncomfortable position of 
either telling the doctor that he or she has not followed the 
advice or, alternatively of lying. To be fully committed to the 
concept of concordance means to see one’s responsibility in 
terms of providing information and opinion and in respecting 
patient autonomy in decision-making, rather than in deciding 
for them. In reality the patient always decides but without 
open communication they frequently do so without telling 
their doctor.
The need for expert knowledge and opinion is still 
important. Quill and Brody (1996) advocate an “enhanced 
autonomy” model in which the patient’s best interests are 
served by actively exchanging ideas, openly discussing and 
negotiating differences and sharing power and inﬂ  uence. 
Even the most independent patient wants to hear their doctor’s 
opinion and some people prefer a more directive approach 
(Cox et al 2004; Swenson et al 2006). The practitioner needs 
the ﬂ  exibility and the skills to explore which approach the 
patient wants.
The practitioner’s most frequent role now becomes 
one of helping patients with decisions they make for 
themselves and supporting them in seeing these through. It 
requires a particular attitude accompanied by the necessary 
communication skills to put it into practice.
Concordance thus represents a radical model of care 
which challenges much of the medical training that many 
practitioners have undergone. The concept cannot be simply 
“bolted on” to traditional behavior. In order to understand 
what is required, we need to examine the processes of the 
consultation in more detail.Therapeutics and Clinical Risk Management 2007:3(6) 1050
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What usually happens in consultations?
Doctors regularly provide information but in only about 2% 
of consultations do they check what patients have under-
stood or thought of these explanations. (Tuckett et al 1985; 
Levinson 1997; Butler et al 1998; Kettunen et al 2001).
Patients are generally passive in consultations. Younger 
patients and white males are more likely to participate in discus-
sions about their medication and younger doctors also seem to 
encourage this (Cox et al 2004). Many patients have their own 
ideas about what is wrong and what may have caused it but they 
do not always articulate them (Cockburn and Pit 1997).
Observations of consultations show that doctors rarely 
explore patients’ ideas, concerns and expectations or their 
understanding and intentions about management (Tuckett 
1985; Levinson 1997). Studies in which consultations were 
recorded showed that doctors think they discuss management 
issues more often than is actually the case and interestingly, 
patients also tended to overestimate how much they were told 
and involved in the consultation (Cox et al 2004).
Side effects are a concern that patients would like to be 
able to discuss with doctors (Coulter 2005). Doctors them-
selves more commonly discuss beneﬁ  ts and the mechanics 
of taking medication (Cox et al 2004). When patients do 
raise the subject of side effects, doctors are more likely to 
either evade the issue or change the medication than enter 
into a discussion to help patients compare possible unwanted 
effects with anticipated beneﬁ  ts. Levinson (1997) in her study 
found that only 10% consultations included mention of any 
adverse effects.
Doctors can draw unwarranted inferences about patient 
expectations, sometimes wrongly assuming patients want 
a prescription. Little et al (2004) found that in situations 
where the doctor thought there was little or no medical 
need, perceived patient pressure was a stronger predictor of 
prescribing than the patient’s actual preference. This may 
simply reﬂ  ect the doctor’s own need to do something which 
is then projected as a patient expectation. The pressure to 
shorten visits and avoid exploring concerns in depth may 
also result in over-prescribing (Epstein 2006).
Why aren’t patients more forthcoming?
Some 30-years ago Byrne and Long (1976) ﬁ  rst described 
how doctors control the consultation process and Strong 
(1979) described ritual aspects of interaction between doctors 
and parents in a pediatric setting. Patients have to manage 
both their illness and also their interaction with healthcare 
services. Questioning can be a risky business. The questioner 
gets more information at the risk of creating tension in the 
consultation if the practitioner is not comfortable or regards 
this as interrogation (Tuckett 1985; Murray et al 2003). 
Active questioning by a patient sometimes reﬂ  ects dissatis-
faction linked to non-adherence, but admitting non-adherence 
risks provoking anger in the provider (Cox et al 2004; Carter 
et al 2005). People frequently act to preserve their dignity and 
self esteem in the eyes of others by ‘saving face’ (Goffman 
1972; Lazare 1987). Thus maintaining a relationship is of 
concern to both patients and doctors (Pollock 2005).
Forms of politeness generally prevail to deal with asym-
metric power relations (Brown and Levinson 1978). This 
applies to patient interactions with all health-care workers 
as a result of both the professional role and the organiza-
tions within which they work (Kettunen et al 2001; Latter 
and Courtenay 2004). Professional status is reinforced by 
patient deference and by avoiding open disagreement and 
conﬂ  ict. If this results in patient agendas not being explored, 
the result may be unwanted prescriptions with potential for 
poor adherence and wasted resources (Butler et al 1998; 
Barry et al 2000).
Dowell and colleagues (2002) applying a strategy based 
on concordance to consultations with patients who had a 
history of adherence problems found what they described 
as a ‘zone of discomfort’ marking a transition between a 
diagnostic and therapeutic encounter. This occurred when 
differences between patient and doctor views were revealed. 
They attributed the improved clinical control and medicines 
taking that subsequently occurred to the process of addressing 
the issue of acceptance of the illness. The ability to discuss 
feelings about the illness was dependent on an improvement 
in the doctor-patient relationship.
Patients recall about 60% of what they have been told and 
what they recall depends on salience and time of presentation, 
the ﬁ  rst thing said being most likely to be remembered (Ley 
1997). Interestingly, prior knowledge and consistency with 
their own views make recall and understanding more likely, 
even when the provider’s explanations are not very clear 
(Punamaki and Kokki 1995; Ley 1997). Further evidence of 
the importance of belief comes from Britten et al (2000) who 
found that patients are much less likely to take medication 
if their own beliefs are in conﬂ  ict with those of healthcare 
professionals and their concerns are not addressed.
Whilst healthcare professionals may feel frustrated by 
the apparent irrationality of patients, when viewed from a 
patient’s perspective, their reservations make absolute sense. 
For the most part they have good reasons for not taking their 
drugs: fear of dependency, concern about side effects and 
hopes that their condition has improved (Pound et al 2005). Therapeutics and Clinical Risk Management 2007:3(6) 1051
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They therefore experiment by varying dosages and having 
drug-free intervals (Donovan and Blake 1992).
Positive behaviors
Better adherence is obtained by practitioners who provide 
information, engage in “positive talk” and specifically 
enquire about adherence (Hall et al 1988). Warmth and 
empathy, self-disclosure, listening attentively to patients’ 
views and providing emotional support result in greater 
satisfaction, improved adherence and lower levels of 
litigation (Stewart 1996; Levinson 1997; Ambady et al 2002; 
Whitcher-Alagna 2002). Patients who view themselves as 
active partners in the process have better adherence and 
health outcomes Schulman (1979).
Creating the right atmosphere for allowing such dis-
cussions is important but not always easy. Patients are 
commonly anxious when they are ill and anxiety adversely 
affects cognition. Too much information too quickly may 
be overwhelming whilst evaluating different options can be 
equally stressful. Uncertainty provokes anxiety especially 
for people with a need for high levels of control (Krupat 
et al 2000; Epstein 2006).
It can be seen that the consultation process is complex and 
maximizing its therapeutic potential requires a relationship 
built on respect with considerable communication skills, care-
ful pacing and a ﬂ  exible approach to the condition, the context 
and the patient (Diem 1997; Krupat 2000; Epstein 2006).
In summary the research reviewing the extent to which 
some elements of concordance occur in consultations found 
few examples of good practice. Crucially, doctors rarely ask 
patients for their own experiences or views about medication, 
a central need for a concordant discussion. Changes to the 
dynamic of the consultation have tended to be superﬁ  cial 
and not addressed the patient as a real partner in the process. 
Awareness, commitment and skills are needed to transform 
the interaction to a genuine partnership. We would assert that 
most, if not all, patients would beneﬁ  t from this approach.
Do doctors and patients want shared 
decision making?
Doctors appear supportive of shared decision making but are 
less conﬁ  dent that this is achieved in practice (Cox et al 2004; 
Edwards and Elwyn 2004). Clinical autonomy is extremely 
important and highly valued by doctors. There is concern that a 
loss of traditional professionalism, greater regulation and public 
accountability, consumerism and a more conﬁ  dent, questioning 
and informed public will adversely affect the doctor-patient 
relationship (Murray et al 2003; Pollock 2006, ch 5). Inevitably 
there is variation, and other doctors actively welcome the more 
informed and questioning patient (McMullan 2006).
Patients also show huge variation in their desire for level of 
involvement and shared decision making. A national survey in 
the USA found that whilst nearly everyone wants to be offered 
choices and asked their opinion, about half prefer to leave 
decisions ultimately to their doctor (Levinson et al 2005). The 
Picker Institute surveyed eight European countries and found 
differences across countries but an average of 50% of people 
said they wanted shared  decision making (Coulter and Magee 
2003). A shared decision-making approach inﬂ  exibly imposed 
by practitioners may be perceived as oppressive by some 
patients (Gambrill 1999; Pollock 2006). Whilst the majority of 
patients prefer patient-centered communication some say they 
actually dislike it and want more directive styles with clear and 
strong advice (Swenson et al 2006). Even this group seems to 
gain satisfaction from an approach more patient-centered than 
that which they overtly espouse (Krupat et al 2000).
Despite changes in society and increasing access to the 
Internet, patients still regard doctors as their primary source 
of information. They prefer to discuss medications with their 
usual doctor, suggesting that continuity of care and a successful 
relationship with their doctor remain important (Cox 2004). The 
quality of the relationship rather than just mechanical exchange of 
information alone is the key determinant for patients and patient-
centeredness is preferred (Krupat et al 2000; Cox et al 2004; 
Epstein 2006; Longo et al 2006). They want reassurance 
supported by clear information and tailored practical advice, to 
feel that their problems have been acknowledged and understood 
and that they are valued as a person rather than as a case (Roter 
1998; Cox et al 2004).
There continues to be a gap between the rhetoric of 
patient-centered medicine and its practice (Coulter 1999, 
2002b). Doctors face the challenge of creating effective 
dialogues with patients in a changing culture where indi-
viduals, government, media, the pharmaceutical industry and 
professional organizations produce conﬂ  icting expectations 
(Elwyn 2004). Despite professionals’ concerns, the evidence 
suggests that patients continue to want and need good thera-
peutic relationships with their doctors, albeit, for many, in a 
slightly different form (Coulter 2005).
Barriers to a change in consulting 
behavior
Time
Intuitively, it would seem inevitable that consultations will 
be longer if doctors are actively exploring patients’ views Therapeutics and Clinical Risk Management 2007:3(6) 1052
Cushing and Metcalfe
about medication, helping them to weigh up risks and beneﬁ  ts 
in order to reach an informed decision (Edwards and Elwyn 
2004). Health service targets and a responsibility to manage 
time for the beneﬁ  t of all patients constitute pressures within 
consultations. Health Services therefore need to be aware that 
encouragement of patient participation may require more 
investment of time at least initially (Edwards et al 2004; 
Metcalfe 2005). The potential beneﬁ  ts are however sub-
stantial and the extra time requirement is probably less than 
appears at ﬁ  rst sight. Most patients are sensitive to the time 
pressures that doctors experience and restrain their desire to 
talk about their concerns (Pollock and Grime 2002). Whilst 
patient-centered consultations take more time initially, they 
are only marginally longer than disease-centered consulta-
tions as practitioners become more proﬁ  cient in this approach 
(Levinson 2000). Lacroix (1992) found that the consequence 
of doctors reﬂ  ecting back the patient’s complaint and con-
cerns and checking the patient’s understanding of medication 
instructions was to increase consultation time by an average 
of 37 seconds. Becoming more skilled can actually improve 
time control (Roter et al 1995; Belle Brown 2003) and 
efﬁ  ciency (Levinson et al 2000).
Skills
Explaining risk is a complicated process and may partly 
explain why practitioners appear to avoid discussing side 
effects. Misselbrook and Armstrong (2001) found that the 
decision to take an anti-hypertensive drug was affected by 
the way in which the health care professional explained risk. 
Practitioners may be concerned this will deter patients, reduce 
trust and hence chances of beneﬁ  t from the drug. Some deci-
sion aids have been developed which show positive beneﬁ  ts 
for patients (O’Connor et al 1999; Ottawa 2006) but there 
appears to be little guidance for physicians on using them 
with patients (Epstein 2006).
Medical training
Scientiﬁ  c evidence, the dramatic success of its application 
to the art of medicine and the previously unquestioned 
belief that doctors expertise is paramount in decisions about 
management have been central to the training of doctors. 
Patients want knowledgeable and skilled doctors and at 
times, particularly in acute situations, doctors have to make 
unilateral decisions in the patient’s best interests. But often 
in healthcare there are a number of options. The emphasis 
on the biomedical model has not prepared doctors for a col-
laborative patient-centered approach to care that explicitly 
takes into account patients’ views.
A willingness to countenance the value and importance 
of the patient’s perspective in management decisions is how-
ever vital to progress, a fact emphasized by the enquiry into 
children’s heart surgery at Bristol Royal Inﬁ  rmary (2001) 
reviewed by Coulter (2002a).
Conventionally doctors have focused on their agenda 
of identiﬁ  cation and treatment of disease. Patients present 
with symptoms of illness and many do not have deﬁ  nable 
disease. Identiﬁ  cation and incorporation of both agendas 
in a management plan provides satisfaction to both parties. 
Levenstein’s (1989) model shown in diagrammatic form in 
Figure 1 provides a useful view of the relationships between 
disease and illness, doctor and patient agendas and the skills 
needed to reach a management plan. The physician is, at best, 
a bridge between the corpus of scientiﬁ  c knowledge, includ-
ing what remains unknown, and the patient’s life. In the past 
30-years, analysis of the consultation process itself and its 
social context has given us the tools to strengthen the bridge 
between what medicine can offer and what patients want but 
incorporation into actual practice has been patchy.
Models for communication
in shared decision making
Except when they are in hospital, it is patients who have to 
manage their medication. The paradox is that patients remain 
largely passive in consultations whilst needing to be active 
in their own medicines management and behavior changes. 
Despite a considerable body of knowledge about negotiation 
and helping behavior change, professional training has not 
drawn upon it. The usual approach in consultations remains 
giving advice with the expectation that professional expertise 
will lead to patient compliance. Health professionals are 
frustratingly aware that this doesn’t work but continue to 
struggle with it for want of a better strategy.
People are more committed to ideas if they hear them-
selves saying them and believe they can carry them out. 
(Bandura 1977; Ajzen and Fishbein 1980; Leventhal 1998). 
Asking patients views, listening and helping them think 
the problem through and make a decision is more effective 
than telling people what to do. Miller and Rollnick (2002) 
describe how motivation to adhere to treatment is inﬂ  uenced 
by the person’s assessment of cost versus beneﬁ  t of follow-
ing the regime and importantly by the person’s conﬁ  dence 
in their ability to do so (self-efﬁ  cacy). Adherence will be 
low if either are low. Rollnick provides an approach vividly 
encapsulated by the phrase “dancing not wrestling”; working 
with rather than struggling against the patient. Respecting 
the person’s right to their own choice is the ﬂ  exible basis Therapeutics and Clinical Risk Management 2007:3(6) 1053
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on which to create collaborative interactions (Rollnick 
et al 2000). This concept is illustrated in Figure 2. It entails 
establishing rapport, checking what the patient wants to 
talk about and what the practitioner thinks is important and 
agreeing priorities.
The patient decides how important the behavior is 
and how conﬁ  dent they are in their ability to make the 
change.
There are two tasks for the practitioner; exchanging infor-
mation and helping the patient to reduce barriers (resistance) 
to making a change. Listening skills are important in 
information exchange so that both parties understand each 
other’s viewpoint. Reluctance or defensiveness either ver-
bally or non-verbally indicates the patient is uncomfortable 
with the approach or information. It can be easily appreciated 
that this demands an increased level of sensitivity and under-
standing of the dynamics of the consultation. This approach 
to discussions on behavior change is equally applicable to 
shared decision-making about medication.
Towle and Godolphin (1999) in deﬁ  ning a set of compe-
tences for both health professionals and patients stress the 
need to ascertain the level of information and involvement 
in decision making that a patient might want. Patients may 
sometimes take on more or less involvement depending on 
their circumstances, the context and the condition (Elwyn 
et al 2003; Makoul and Clayman 2006). Moreover, decisions 
are not always made when the problem is ﬁ  rst discussed and 
follow up is essential to come to a decision and to review 
ones that have been made. Relapse is common (Prochaska 
1997) so open discussions which acknowledge the possibility 
that the patient may want to stop or change medication are 
essential.
The Ottawa Personal Decision Guide (2006) is a self 
assessment form designed to help individuals work through 
difﬁ  cult decisions in a systematic way. Whilst not appropri-
ate for everyone to complete independently, the analytical 
structure could also be useful to allow professionals to work 
through choices with their patients.
Patient presents unwell
Parallel search of two content frameworks
Process
t n e t n o C Content
Disease Framework                            Rapport & Relationship                                  Illness Framework
(“Doctor’s Agenda”)                           Attentive listening                                         (“Patient’s Agenda”)
History                                                 Question style:open to closed                Ideas
Physical examination                        Clarification                                         Concerns
Investigations                                      Explaining                                            Expectations
Negotiating
Shared Decision Making
Summarising                                                 
Differential diagnosis                       t n e i t a p e h t g n i d n a t s r e d n U
Integration
Problem - Orientated Medical Record
Management Plan
Figure 1 The patient-centered clinical interview (adapted from Levenstein et al 1989).Therapeutics and Clinical Risk Management 2007:3(6) 1054
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Figure 2 Key tasks in consultations about behavior change. Reprinted from Health Behavior Change: A Guide for Practitioners. Rollnick S, Mason P and Butler C, p 12, 
London, Churchill Livingstone. Copyright (2000), with permission from Elsevier.
Implications for changes
in practitioner behavior
The barriers to change of consulting behavior should not to 
be underestimated. The practitioner needs to recognize its 
importance and to feel it is achievable. The beneﬁ  ts include 
a greater understanding of management of patients’ condi-
tions, better relationships with and hence more satisﬁ  ed 
patients and, potentially at least, better health outcomes 
(Elwyn et al 2003).
Britten (2004) cites ﬁ  ve pre-requisites for concordance 
in consultations which include:
•  A willingness to share power and a commitment to giving 
appropriate weight to patient values and goals
•  Open discussion of the options with explicit enquiry as 
to patients views without making assumptions
•  Adequate sharing of information including uncertainties 
to arrive at a decision
•  Listening as much as talking
•  Time.
Speciﬁ  c problems in relation to medication discussions 
have been identiﬁ  ed (Cox et al 2004) and we make some 
suggestions for how these could be addressed in Table 1. 
Steps for achieving concordant consultations are outlined 
in Table 2.
Training
A number of intervention studies have shown how training 
improves healthcare professionals’ shared decision mak-
ing skills (Aufseesser-Stein et al 1992; Lacroix et al 1992; 
Clark et al 1998; Edwards et al 2004; Longo et al 2006). 
However to date the rigor of such studies has been poor and 
their translation into practice limited or questionable (Davis 
et al 2003; Edwards and Elwyn 2004; Grifﬁ  n et al 2004; 
Fellowes et al 2007).Therapeutics and Clinical Risk Management 2007:3(6) 1055
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Table 1 Areas for improvement in medicines discussions and suggested actions
Areas for improvement  Suggested action
Doctors don’t always refer to the medicine by name  Tell the patient:
   The name of the drug and what it does
Doctors rarely ask patients’ experiences and views –   Ask patients opinion and explore them.
these are central to concordance  “How are you feeling about your illness … and its management”
  “How are you ﬁ  nding the medication?”
  “What concerns you the most?”
  “How do you feel about taking it?”
Non-adherence rarely explored – if patient mentioned   Anticipate and explore non-adherence.
it doctors likely to change medication or provide   “Often patients have difﬁ  culty with or concerns about taking
education  medication. How are you getting on?”
Doctors talk more about beneﬁ  ts than side effects,   “It’s important for me to tell patients not only about the
risks or precautions beneﬁ  ts but also other effects of medicines which can
  sometimes occur. This is to help you decide if you want to
  take it. The common ones with this medication are …”
Patients thought GPs reluctant to discuss side effects  Be open to listening and taking concerns seriously. 
  “It sounds like that’s been causing you some problems …”
  “What do you think about that?”
Practitioners did not express their own views about   Give your opinion.
medicines. Patients want to hear these  “My recommendation would be …”
  “My concern would be …” 
  “I think this would be best because …”
Doctors communication skills do however change 
following intensive training and these changes persist into 
clinical practice (Fallowﬁ  eld and Jenkins 2003).
Whilst undergraduate curricula have for some time 
included communication skill training (Hargie et al 1998), 
post-graduate competences and training needs, though well 
established in Primary Care are only just beginning to be 
addressed in hospitals. The junior doctor emerging into 
busy hospital practice easily forgets all he has learnt in the 
calm environment of medical school and will usually adopt 
a senior colleague, who may or may not be appropriate, 
as a role model. This tendency also leads to an inﬂ  exible 
consultation style which does not acknowledge that different 
patients need different approaches. Practice with feedback 
and support in clinical settings are essential parts of the 
training process (Maguire and Pitceathly 2002; Heaven et al 
2006). It is difﬁ  cult to incorporate this into the busy profes-
sional lives of both trainees and trainers and whilst there are 
many skilled communicators amongst the latter, the ability 
to analyze a consultation and thus aid learning is much less 
widely available.
Conclusion
In this article we have attempted to reframe the issue from 
one of adherence to a treatment deﬁ  ned by the doctor towards 
optimizing medicines management with patient involvement. 
We have described the communication process which is 
central to concordance and outlined the skills which health 
care professionals need to use if they wish to embrace the 
process. Concordance relies on open discussions about the 
condition and treatment options. Making decisions based 
upon shared information and respect for patient belief results 
in “compliance” and “adherence” becoming almost an irrel-
evance since the primary decision is made by the patient. The 
result is likely to be patients committed to actions they have 
chosen and thus optimized medicines management. It may 
also result in fewer prescriptions being issued.
The strategy is, therefore, one of establishing a relation-
ship which promotes open discussion using communication 
skills effectively from the outset. Four areas need to be 
explored with patients:
•  Their understanding of the diagnosis and options for 
treatment.
•  Their beliefs and concerns about the condition and the 
options for treatment.
•  The challenges they anticipate in trying to adhere to a 
particular therapeutic regime.
•  Practical ways of helping them with these difﬁ  culties.
Optimizing medicines management is not a tag-on at the 
end of a consultation but is dependant upon and part of the 
whole consultation. We hope to have encouraged the reader 
to see the value and satisfaction to be obtained from seeking 
a partnership with patients utilizing the approaches laid out in 
the last part of this paper. This change in clinical style cannot Therapeutics and Clinical Risk Management 2007:3(6) 1056
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be achieved overnight or simply by reading a book. We would 
encourage the interested reader to consider one of the many 
courses on medical communication skills which are now avail-
able. On these, the doctor can try out new techniques in safety 
with the help of actors, role-play and group discussion to build 
their proﬁ  ciency in communication skills for concordant con-
sultations aimed at optimizing medicines management. Health-
care systems would, in our opinion beneﬁ  t from promotion of 
communication skills education and training particularly in the 
early post-graduate years of hospital practice.
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